Skip to content
sellWeak cluster of 410b5-1 plan

Jeffrey Stuart Peters sold $422k of MGNX

Senior VP and General Counsel at MACROGENICS INC. 19,625 shares at an average of $21.50, traded Mar 6, 2024, filed Mar 8, 2024.

Warning score
31
Value
$422k
19,625 shares
Holdings after
8,895
-69% from before
From 52-week low
+379%
low $4.48, close $21.47
From 52-week high
0%
high $21.47, as of Mar 6, 2024

Score components

  • Role
    Officer
    +15
  • Trade size
    $422k at market
    +16
  • Share of holdings sold
    Sold 69% of holdings
    +20
  • Cluster
    4 insiders selling within 14 days
    +15
  • Exercise and sell
    Shares came from an option exercise in the same filing
    -15
  • 10b5-1 plan
    Pre-scheduled under a 10b5-1 plan
    -20

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m +4.6%, 3m -74.0%, 6m -81.4%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

MGNXOct 13, 2026 · close 3.42
Since filing Mar 8, 2024: -80.4%SPY +57.0% · excess -137.4%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001125345-24-000063, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Mar 6, 2024MOption exercise
Common Stock10b5-1
+10,875$11.50$125k19,770Mar 8, 2024
Mar 6, 2024MOption exercise
Common Stock10b5-1
+8,750$10.15$89k28,520Mar 8, 2024
Mar 6, 2024SOpen-market sale
Common Stock10b5-1
-19,625$21.50$422k8,895Mar 8, 2024
Mar 6, 2024MOption exercise
Employee stock option (right to buy)derivative10b5-1
-10,875$11.50$125k0Mar 8, 2024
Mar 6, 2024MOption exercise
Employee stock option (right to buy)derivative10b5-1
-8,750$10.15$89k39,375Mar 8, 2024

Related signals

Other insiders at MACROGENICS INC and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
26Weak
MGNXsell10b5-1
MACROGENICS INC
Jeffrey Stuart Peters
Senior VP, GC, and Secretary
$129k
31,105 shares
-100%
36Weak
MGNXbuy
MACROGENICS INC
William K Heiden
director
$151k
100,000 shares
+909%
22Weak
MGNXsell10b5-1
MACROGENICS INC
Jeffrey Stuart Peters
Senior VP and General Counsel
$799k
51,395 shares
-100%
42Moderate
MGNXsell 410b5-1
MACROGENICS INC
James Karrels
SVP, CFO and Secretary
$615k
30,000 shares
-15%
27Weak
MGNXsell 410b5-1
MACROGENICS INC
Thomas Spitznagel
Sr VP, Technical Ops
$200k
10,000 shares
-55%
42Moderate
MGNXsell 410b5-1
MACROGENICS INC
Eric Blasius Risser
Chief Operating Officer
$814k
41,159 shares
-51%
44Moderate
MGNXsell 410b5-1
MACROGENICS INC
Jeffrey Stuart Peters
Senior VP and General Counsel
$278k
16,124 shares
-64%
10Weak
MGNXsell 210b5-1
MACROGENICS INC
Ezio Bonvini
Sr VP, Research & CSO
$60k
3,334 shares
-4%
33Weak
MGNXsell 210b5-1
MACROGENICS INC
Jeffrey Stuart Peters
Senior VP and General Counsel
$1.3M
76,251 shares
-100%
20Weak
MGNXsell 210b5-1
MACROGENICS INC
Ezio Bonvini
Sr VP, Research & CSO
$200k
13,316 shares
-15%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Jeffrey Stuart Peters sold $422k of MGNX | InsiderTell